BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  Cempra Pharmaceuticals, Inc. Announces Results of Intravenous Solithromycin Phase 1 Study

  October 8, 2012

   · 

  3 min read
• Drug Development

  Biotech Support Group Release: Virus Purification and Isolation Using Viraffinity™ for Anti-HIV Drug Development Research

  October 8, 2012

   · 

  6 min read
• Valeant Pharmaceuticals International to Announce 2012 Third Quarter Results on October 31, 2012

  October 8, 2012

   · 

  1 min read
• Business

  Mucosis B.V. Signs Research and License Option Agreement With Crucell N.V.

  October 8, 2012

   · 

  2 min read
• BioCapital

  Gliknik Inc. Raises $4.9 Million in Series B Financing Led by Baxter Ventures

  October 8, 2012

   · 

  2 min read
• Ocimum Biosolutions Inc. Wins 2012 Customer Value Enhancement Award for Lab Information Management

  October 8, 2012

   · 

  3 min read
• Business

  4-Antibody AG Receives Additional Milestone Payments From Human Genome Sciences, Inc.

  October 8, 2012

   · 

  2 min read
• Drug Development

  Grifols Announces First Patient Enrolled and Dosed in Phase II Trial of Alpha-1 HC Aerosol to Treat Cystic Fibrosis

  October 8, 2012

   · 

  2 min read
• Drug Development

  Isconova’s Adjuvant Matrix-M™ in Clinical Trial With Malaria Vaccine

  October 8, 2012

   · 

  4 min read
• Biotech Beach

  Response Genetics, Inc. Regains Compliance With NASDAQ Listing Standards

  October 8, 2012

   · 

  3 min read